A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
about
Role of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphomaRadioimmunotherapy of human tumoursRituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual MeetingRadioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review.Efficacy and safety of yttrium-90 ibritumomab tiuxetan in Japanese patients with non-Hodgkin lymphoma.Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.Cancer radioimmunotherapy.The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation.Initial management strategies for follicular lymphoma.A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy.Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applications.Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma.Radioimmunotherapy for B-cell non-hodgkin lymphomas.Efficacy and safety evaluation of fludarabine-based chemotherapy regimen for patients with non-Hodgkin lymphoma: A meta-analysis.Novel therapies for aggressive B-cell lymphomaWhither Radioimmunotherapy: To Be or Not To Be?The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF
P2860
Q27000310-4F028315-DB1F-43AF-944C-5683984D9295Q28088825-C2309A0F-8A41-4585-9414-32C7F5766224Q28390181-4982185F-98C5-4E81-8F2A-9C8C39E3B3C0Q33380518-F3A7545A-8BD0-4D1D-B077-E239887238ACQ33402171-D84C240A-B9AC-4A6E-B36D-67623AC3CBC4Q33645793-E86E06B1-5A3D-4C3A-92C9-167E3A575CFAQ35070045-A9D99D5B-75A1-41FB-B874-D98164120F60Q35867299-6764E132-B373-4C3F-830C-55D8E45B7F83Q36655216-F4CD9439-55F8-4E6B-9E11-2F3CE5BDC0B5Q37169112-8C158F34-7890-4B99-AF08-F65512CC89A4Q37424784-30B0E3A8-1391-47DD-A061-98953C4DC660Q37752447-B81BA640-7E0C-4909-9598-2B89455A31CDQ37824258-73866CC3-F001-44CF-ADD3-6FB68B8B1C31Q38019790-5729A579-C219-47BB-BAFE-DA519E5AC0EDQ41521509-274641C4-3D53-4EE8-AD0D-8FE282D9E7F5Q42011578-AB0C46EA-596C-427E-B879-E90B2D25F356Q50203410-19243AB7-F906-4275-8C75-7E97756FF51FQ56986459-00742D25-2D44-44BE-81CC-DB116C6CE69C
P2860
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A phase 2 trial of fludarabine ...... licular, non-Hodgkin lymphoma.
@ast
A phase 2 trial of fludarabine ...... licular, non-Hodgkin lymphoma.
@en
type
label
A phase 2 trial of fludarabine ...... licular, non-Hodgkin lymphoma.
@ast
A phase 2 trial of fludarabine ...... licular, non-Hodgkin lymphoma.
@en
prefLabel
A phase 2 trial of fludarabine ...... licular, non-Hodgkin lymphoma.
@ast
A phase 2 trial of fludarabine ...... licular, non-Hodgkin lymphoma.
@en
P2093
P50
P356
P1433
P1476
A phase 2 trial of fludarabine ...... licular, non-Hodgkin lymphoma.
@en
P2093
Alessio Perrotti
Mariapaola Fina
Monica Tani
Stefano Fanti
Vittorio Stefoni
P304
P356
10.1002/CNCR.23236
P407
P577
2008-02-01T00:00:00Z